Control of triple-negative breast cancer using ex vivo self-enriched, costimulated NKG2D CAR T cells

BACKGROUND: Triple-negative breast cancer (TNBC) is an aggressive disease that currently lacks effective targeted therapy. NKG2D ligands (NKG2DLs) are expressed on various tumor types and immunosuppressive cells within tumor microenvironments, providing suitable targets for cancer therapy. METHODS:...

Descripción completa

Detalles Bibliográficos
Autores principales: Han, Yali, Xie, Wei, Song, De-Gang, Powell, Daniel J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6035420/
https://www.ncbi.nlm.nih.gov/pubmed/29980239
http://dx.doi.org/10.1186/s13045-018-0635-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6035420/
https://www.ncbi.nlm.nih.gov/pubmed/29980239
http://dx.doi.org/10.1186/s13045-018-0635-z

Ejemplares similares